Massachusetts Blue Cross has used an “Alternative Quality Contract” with provider groups for several years. Prior research suggests that it has had modest cost or quality impacts and a new study carried by Health Affairs looks at the effect on mental health services. (HA Article) The researchers compared receipt of mental health services by members covered by the AQC with a similar group under more traditional provider contract arrangements. Under the AQC, providers are paid a fixed, risk-adjusted amount for all primary and specialty care for members choosing the provider. This method could encourage providers to limit services, but the AQC also provides bonuses for meeting quality measure targets, which could ameliorate any effect from the financial incentive to control utilization. For mental health in particular, where utilization is often inappropriate or ineffective, being at risk might encourage a provider to carefully control services or to more fully integrate behavioral and primary care, which has been shown to result in better outcomes for patients. Among those AQC providers who were at risk for mental health services, there was a slight decline in both mental health visits and spending, compared to those providers not at risk for such services. The patients who used mental health services had comparable performance on quality measures related to diabetes and cardiovascular care to patients who did not use mental health services, suggesting that care neither worsened nor improved for these patients. A set of providers and others who were interviewed about the use of mental health services under the AQC basically said it had no impact. Factors in this were a focus on other issues like “code capture” (i.e., risk payment revenue maximization), limited ability of the chosen behavioral health quality measures to incent changes in care, and limited mental health provider capacity and capabilities. In general, value-based purchasing methods are being oversold on their ability to affect change.
Early Results From a Value-based Provider Contract
By Kevin RocheJanuary 8, 2016Commentary
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
Another example of over-priced companies trying to find some way to survive in the post-epidemic financial world. Transcarent, which does something, somehow to “access high quality, affordable care” is buying...
March 6, 2023
In an attempt to swiftly revive two floundering health care companies, a PE firm has announced the merger and recapitalization of Revive Health and SwiftMD. You know they are...
January 30, 2023
Investors have not yet learned their lesson, as Pearl Health gathers a new round of $75 million in capital for its business of supporting physicians who want to participate in...
January 30, 2023
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace
March 21, 2023
Minnesota’s New Energy Insanity, Part 7
Minnesota is a particularly poor place to rely on solar power, but other states aren't…
March 21, 2023
A Quick SVB Follow-up
As I suspected, the SVB saga is primarily one of regulatory malfeasance, coupled with political…
March 19, 2023
Tom Frieden Speaks in the WSJ
A public health expert writes an article for the WSJ which amply demonstrates why Americans…